Project Grant R25AG092317
- The National Institute on Aging (NIA), through its Aging Research Federal Grant Program (CFDA 93.866), awarded a $2,374,537 Project Grant to the Regents of the University of California, San Francisco (UCSF) on Sep 15, 2024. The grant supports a research project titled "Personal Values in Dementia Experience, Caregiving, and Research" that aims to examine how changes in personal values and self-narratives among people with different dementia syndromes impact caregivers and caregiving...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $372,904 to The University of Texas Health Science Center at San Antonio to advance cross-national research on aging and cognitive function. The 5-year grant, awarded on September 20, 2025, supports an annual program that recruits, trains, and mentors 16 post-graduate participants dedicated to mastering Down syndrome (DS) clinical research. The program offers hands-on DS clinical...
- The National Institute on Aging (NIA) awarded a $558,193 Cooperative Agreement under the Aging Research Federal Grant Program (CFDA 93.866) to The Regents of the University of California, San Francisco (UCSF) for the "Bridging Research Infrastructure for Dementia Gaps in East Africa (BRIDGE-AFRICA)" project. The funding will be used to build research infrastructure for Alzheimer's disease and related dementias (ADRD) in East Africa, building on UCSF's existing expertise and...
- This Project Grant award, titled "Investigating Neurosciences, A Summer Program to Ignite Research and Education (INSPIRE)", is funded by the National Institute on Aging (CFDA 93.866 - Aging Research) with $215,998.00 and will be implemented from September 2025 to May 2030. The goal of this program is to create an immersive research education initiative that will attract undergraduate science majors to ultimately increase the number of early-stage investigators pursuing careers in...
- The Icahn School of Medicine at Mount Sinai received a $307,801 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research program) to develop and implement the Postbaccalaureate Alzheimer's Disease Development Initiative (PADDI), a two-year program to train postbaccalaureate students about Alzheimer's disease and related dementia research methodologies and the ethical conduct of research. The program aims to address a lack of ethnic and racial diversity among...
- This federal Project Grant award of $372,690, provided by the National Institute on Aging (CFDA 93.866 Aging Research), aims to comprehensively understand the heterogeneous causal pathophysiology of Alzheimer's disease (AD). The key objectives are to: (1) develop new statistical methods for uncovering heterogeneous causal relationships among amyloid-beta, tau accumulation, and cognition across diverse AD datasets; (2) apply these methods to reveal optimal treatment windows and target populations...
- This federal Project Grant award of $3,221,450.00 from the National Institute on Aging (CFDA 93.866 Aging Research) supports research to define how neuronal hyperexcitability in the retrosplenial cortex (RSC) contributes to the development of Alzheimer's disease (AD)-related behavioral deficits in mouse models. The research aims to determine the effect of inhibiting RSC layer 5 cells on spatial memory and navigation, as well as when hyperexcitability emerges in these cells across different AD...
- The National Institute on Aging awarded a $1,198,947 Project Grant under the Aging Research program (CFDA 93.866) to The Regents of the University of California, San Francisco (UCSF) on September 30, 2023. The grant will fund research to investigate the neuroprotective effects of a blood-derived enzyme called GPLD1 on Alzheimer's disease pathology. Specifically, the project aims to: 1) examine the relationships between GPLD1, physical activity, immunovascular function, and cognition in older...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $356,174 to The Regents of the University of California, San Francisco (UCSF) to conduct in vivo testing of structure-based vaccine candidates targeting Alzheimer's disease. The goal is to determine the efficacy of an active immunization strategy in preserving cognitive and neural function by slowing the formation of amyloid-beta or tau protein aggregation in the brain. The research will use...
- The University of Kentucky Research Foundation was awarded a $418,309 Project Grant by the National Institute on Aging (NIA) on August 15, 2025 under the Aging Research Federal Grant Program (CFDA 93.866) to establish the Kentucky Postbaccalaureate Alzheimer's Disease (KYPAD) Research Education Program. This program will provide an intensive research experience for recent biomedical and behavioral science graduates to prepare them for advanced degree programs focused on Alzheimer's disease and...
The University of California, San Francisco (UCSF) was awarded a $109,084 Project Grant from the National Institute on Aging (CFDA 93.866 - Aging Research) on August 15, 2025 to support the UCSF Research in Alzheimer's Disease and Dementia (RADD) Summer Intern Program. This program will annually provide five public high school students from underrepresented backgrounds with research internships in UCSF laboratories focused on improving understanding and treatments for Alzheimer's disease and related dementias. The key objectives of the program are to: 1) Develop students' scientific research skills, 2) Build awareness of Alzheimer's/dementia research and related biomedical careers, and 3) Foster college readiness for these underrepresented students. The project will run through May 31, 2030, with the goal of increasing participation in Alzheimer's/dementia research careers among students from backgrounds underrepresented in the biomedical sciences.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $109.1k | 8/14/25 |